Skip to Content

M 40 (Clorazepate Dipotassium 7.5 mg)

Pill with imprint M 40 is Orange, Round and has been identified as Clorazepate Dipotassium 7.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Clorazepate is used in the treatment of anxiety; seizure prevention; alcohol withdrawal and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 7.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for M 40

Clorazepate dipotassium 7.5 mg M 40
Clorazepate dipotassium 7.5 mg M 40  Front
Clorazepate dipotassium 7.5 mg M 40  Back
Clorazepate dipotassium 7.5 mg M 40

Clorazepate Dipotassium

M 40
7.5 mg
8.00 mm
Prescription only
Drug Class:
Pregnancy Category:
N - Not classified
CSA Schedule:
4 - Some potential for abuse
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
croscarmellose sodium
FD&C Yellow No. 6
magnesium oxide
magnesium stearate
microcrystalline cellulose
potassium carbonate
sodium chloride
sodium lauryl sulfate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
49999-0674 Lake Erie Medical and Surgical Supply (repackager)
43063-0164 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.